Contrast Enhancement Phases
On this page
Direct answer
Timing of acquisition, not scanner power, decides what a contrast CT can diagnose. After an intravenous bolus, the late arterial phase at roughly 25-35 seconds shows hypervascular lesions at their brightest, the portal venous phase at 60-70 seconds is the routine parenchymal workhorse, and delayed phases at 3-5 minutes expose washout and fibrotic retention. Hepatocellular carcinoma's signature is arterial hyperenhancement with portal or delayed washout; haemangioma shows peripheral, discontinuous, nodular enhancement progressing to complete fill-in; cholangiocarcinoma enhances progressively and retains contrast on delay; focal nodular hyperplasia lights up early with a central scar that enhances late. In the kidney, the nephrographic phase (90-120 seconds) detects renal cell carcinoma best, while the excretory phase outlines the collecting system.
What you must remember
- Phase clock: late arterial about 25-35 seconds, portal venous 60-70 seconds, equilibrium or delayed 3-5 minutes — quote seconds, not adjectives.
- HCC signature: intense arterial enhancement with washout on portal venous or delayed phases in a cirrhotic liver — the LI-RADS backbone; capsule appearance on delay further upgrades the category.
- Haemangioma: peripheral nodular discontinuous enhancement with centripetal fill-in persisting on delay, isodense to the aorta at each phase — blood-pool behaviour, not tumour behaviour.
- Focal nodular hyperplasia versus adenoma: FNH is homogeneously bright arterial with a central scar enhancing on delay; adenomas enhance strongly but variably and carry rupture risk (oral contraceptive link), a classic pair in young women.
- Cholangiocarcinoma: hypovascular early with progressive, delayed retention (fibrous stroma), plus delayed capsular retraction — the mirror image of HCC kinetics.
- Renal phases: corticomedullary 25-40 seconds (vascular anatomy), nephrographic 90-120 seconds (most sensitive for RCC), excretory 3-5 minutes (collecting system, urothelial lesions); a lesion enhancing over 20 HU from baseline is solid, not cystic.
- Adrenal washout: on a 15-minute delayed sequence, an adenoma washes out over 60% absolute (over 40% relative) versus persistent enhancement in metastases — the workhorse of incidentaloma characterisation.
- Pancreatic protocol: a dedicated pancreatic phase around 35-45 seconds maximises parenchymal enhancement and tumour-to-gland contrast for ductal adenocarcinoma.
One lesion, four clocks
A 56-year-old cirrhotic under hepatoma surveillance. On the arterial phase, a 2.5 cm right lobe nodule blazes brighter than the surrounding liver; on the portal venous and delayed sequences it falls duller than background — enhancement then washout, the kinetic fingerprint of hepatocellular carcinoma, and under LI-RADS a category 5 lesion in a cirrhotic liver that can be diagnosed radiologically without biopsy. Substitute the contrast pair the exam prefers: the same nodule showing peripheral nodular enhancement at the margins at 30 seconds, coalescing centrally by 3 minutes and staying isodense with blood pools at every time point — haemangioma, biopsy contraindicated (bleeding risk), no further work-up. Third substitution: an ill-defined left lobe mass, hypodense arterial, gradually denser on each delayed image with overlying capsular retraction — cholangiocarcinoma, and the surgical question shifts from liver resection to biliary drainage and staging. The physics is identical in all three; only the clock position of the photograph changes, which is why "which phase" is the first question a radiologist asks before naming any liver lesion.
Phase-mismatch mistakes
Treating arterial hyperenhancement as synonymous with malignancy forgets that the arterial phase also displays benign physiology — FNH, adenoma, arterioportal shunts and even focal fat sparing can glow; washout behaviour, not brightness alone, carries the diagnostic weight. Second, phase-mismatch errors: a "hypervascular renal lesion" read on a corticomedullary study may be merely normal medulla waiting for the nephrographic phase, which is precisely why renal mass protocols mandate the 90-120 second acquisition. Third, timing vocabulary confusion — "arterial phase" in an aortic-dissection or circle-of-Willis study means about 20-25 seconds (pure arterial), whereas hepatic "late arterial" is nearer 35 seconds after arterial arrival; exam stems exploit exactly this gap. Also remember that poor cardiac output and central venous access shift every clock, so a "badly timed" study is a physiological reading, not a failed one.
Frequently asked questions
What are the standard abdominal contrast phases and their timings?
Late arterial at roughly 25-35 seconds, portal venous at 60-70 seconds, and delayed at 3-5 minutes, each answering a different lesion question.
What enhancement pattern characterises hepatocellular carcinoma?
Arterial phase hyperenhancement followed by washout relative to background liver on portal venous or delayed images, often with an enhancing capsule on delay — the LI-RADS major criteria.
How does a haemangioma enhance?
Peripheral, discontinuous, nodular enhancement progressing centripetally to complete fill-in on delayed images, tracking blood-pool density at every phase.
Which phase best detects renal cell carcinoma?
The nephrographic phase at 90-120 seconds, when medulla and cortex are uniformly enhanced and even small hypovascular tumours stand out as hypoattenuating lesions.
What is adrenal washout characterisation?
An adrenal mass measured at baseline and 15 minutes' delay: adenomas lose over 60% absolute (over 40% relative) attenuation, while metastases retain contrast — separating the incidentaloma without biopsy.